Western Wealth Management’s Alpine Immune Sciences, Inc. Common Stock ALPN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-12,070
| Closed | -$478K | – | 679 |
|
|
2024
Q1 | $478K | Buy |
12,070
+70
| +0.6% | +$2.78K | 0.04% | 376 |
|
|
2023
Q4 | $229K | Hold |
12,000
| – | – | 0.02% | 625 |
|
|
2023
Q3 | $137K | Hold |
12,000
| – | – | 0.01% | 630 |
|
|
2023
Q2 | $123K | Hold |
12,000
| – | – | 0.01% | 625 |
|
|
2023
Q1 | $92.6K | Hold |
12,000
| – | – | 0.01% | 624 |
|
|
2022
Q4 | $88.2K | Sell |
12,000
-12,000
| -50% | -$88.2K | 0.01% | 595 |
|
|
2022
Q3 | $172K | Sell |
24,000
-1,120
| -4% | -$8.03K | 0.01% | 762 |
|
|
2022
Q2 | $214K | Buy |
+25,120
| New | +$214K | 0.01% | 720 |
|
|
2022
Q1 | – | Sell |
-12,360
| Closed | -$171K | – | 851 |
|
|
2021
Q4 | $171K | Buy |
+12,360
| New | +$171K | 0.02% | 584 |
|
|
2021
Q2 | $108K | Buy |
+12,000
| New | +$108K | 0.01% | 615 |
|